stockrowMicrobot Medical Inc.
MBOT Healthcare Medical Devices
- Revenue
- +1,047.6%
- EPS
- +20.0%
- Free cash flow
- −98.7%
Quarter to June 2026, against a year earlier
Follow MBOT
Alert me
Microbot Medical Inc. (MBOT) EV/Sales
As of 5 November 2026, Microbot Medical Inc. (MBOT) trades at a EV/Sales of 15.0×. Over the past ten years it has ranged from −14.4× (March 2020) to 1,042× (April 2016); the current reading is higher than 23% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 160× | (66.38%) |
| Mar 2026 | 475× | 1,272.04% |
| Sep 2015 | 34.6× | 3.76% |
| Jun 2015 | 33.4× | (51.72%) |
| 1 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NYXH Nyxoah SA compare | 0.1× |
| OM Outset Medical, Inc. compare | 0.3× |
| LNSR LENSAR, Inc. compare | 1.0× |
| ZOMDF Zomedica Corp. compare | 1.3× |
| ECOR electroCore, Inc. compare | 2.1× |
| HYPR Hyperfine, Inc. compare | 2.3× |
| LUCD Lucid Diagnostics Inc. compare | 11.3× |
| MBOT Microbot Medical Inc. | 15.0× |
| SERA Sera Prognostics, Inc. compare | 641× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)